These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18841804)

  • 81. The effect of CA1 administration of orexin-A on hippocampal expression of COX-2 and BDNF in a rat model of orofacial pain.
    Kooshki R; Abbasnejad M; Esmaeili-Mahani S; Raoof M
    Arq Neuropsiquiatr; 2018 Sep; 76(9):603-608. PubMed ID: 30365624
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Neonatal manipulation of oxytocin prevents lipopolysaccharide-induced decrease in gene expression of growth factors in two developmental stages of the female rat.
    Bakos J; Lestanova Z; Strbak V; Havranek T; Bacova Z
    Neuropeptides; 2014 Oct; 48(5):281-6. PubMed ID: 25047873
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Rotigotine, a dopamine receptor agonist, increased BDNF protein levels in the rat cortex and hippocampus.
    Adachi N; Yoshimura A; Chiba S; Ogawa S; Kunugi H
    Neurosci Lett; 2018 Jan; 662():44-50. PubMed ID: 28993209
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Robust changes in expression of brain-derived neurotrophic factor (BDNF) mRNA and protein across the brain do not translate to detectable changes in BDNF levels in CSF or plasma.
    Lanz TA; Bove SE; Pilsmaker CD; Mariga A; Drummond EM; Cadelina GW; Adamowicz WO; Swetter BJ; Carmel S; Dumin JA; Kleiman RJ
    Biomarkers; 2012 Sep; 17(6):524-31. PubMed ID: 22672085
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Early phase of plasticity-related gene regulation and SRF dependent transcription in the hippocampus.
    Iacono G; Altafini C; Torre V
    PLoS One; 2013; 8(7):e68078. PubMed ID: 23935853
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Effects of heptapeptide selank on the content of monoamines and their metabolites in the brain of BALB/C and C57Bl/6 mice: a comparative study].
    Narkevich VB; Kudrin VS; Klodt PM; Pokrovskiĭ AA; Kozlovskaia MM; Maĭskiĭ AI; Raevskiĭ KS
    Eksp Klin Farmakol; 2008; 71(5):8-12. PubMed ID: 19093364
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Experimental optimization of learning and memory processes by selank].
    Semenova TP; Kozlovskiĭ II; Zakharova NM; Kozlovskaia MM
    Eksp Klin Farmakol; 2010 Aug; 73(8):2-5. PubMed ID: 20919548
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Comparison of the effects of selank and tuftsin on the metabolism of serotonin in the brain of rats pretreated with PCPA].
    Semenova TP; kozlovskiĭ II; Zakharova NM; Kozlovskaia MM
    Eksp Klin Farmakol; 2009; 72(4):6-8. PubMed ID: 19803361
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Transcriptome alteration in hippocampus under the treatment of tuftsin analog Selank].
    Kolomin TA; Agapova TIu; Agniullin IaV; Shram SI; Shadrina MI; Slominskiĭ PA; Limborskaia SA; Miasoedov IF
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2013; 63(3):365-74. PubMed ID: 24450168
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The temporary dynamics of inflammation-related genes expression under tuftsin analog Selank action.
    Kolomin T; Morozova M; Volkova A; Shadrina M; Andreeva L; Slominsky P; Limborska S; Myasoedov N
    Mol Immunol; 2014 Mar; 58(1):50-5. PubMed ID: 24291245
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [The role of opioid system in peculiarities of anti-anxiety effect of peptide anxiolytic selank].
    Kozlovskiĭ II; Andreeva LA; Kozlovskaia MM; Nadorova AV; Kolik LG
    Eksp Klin Farmakol; 2012; 75(2):10-3. PubMed ID: 22550852
    [TBL] [Abstract][Full Text] [Related]  

  • 92. GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells.
    Filatova E; Kasian A; Kolomin T; Rybalkina E; Alieva A; Andreeva L; Limborska S; Myasoedov N; Pavlova G; Slominsky P; Shadrina M
    Front Pharmacol; 2017; 8():89. PubMed ID: 28293190
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Modulation of BDNF and TrkB expression in rat hippocampus in response to acute neurotoxicity by diethyldithiocarbamate.
    Micheli MR; Bova R; Laurenzi MA; Bazzucchi M; Grassi Zucconi G
    Neurosci Lett; 2006 Dec; 410(1):66-70. PubMed ID: 17052849
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Effects of quetiapine on the brain-derived neurotrophic factor expression in the hippocampus and neocortex of rats.
    Park SW; Lee SK; Kim JM; Yoon JS; Kim YH
    Neurosci Lett; 2006 Jul; 402(1-2):25-9. PubMed ID: 16713676
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Intranasal administration of the peptide Selank regulates BDNF expression in the rat hippocampus in vivo.
    Inozemtseva LS; Karpenko EA; Dolotov OV; Levitskaya NG; Kamensky AA; Andreeva LA; Grivennikov IA
    Dokl Biol Sci; 2008; 421():241-3. PubMed ID: 18841804
    [No Abstract]   [Full Text] [Related]  

  • 96. Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats.
    Kolik LG; Nadorova AV; Antipova TA; Kruglov SV; Kudrin VS; Durnev AD
    Bull Exp Biol Med; 2019 Sep; 167(5):641-644. PubMed ID: 31625062
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Effects of chronic ethanol administration on the expression levels of neurotrophic factors in the rat hippocampus.
    Okamoto H; Miki T; Lee KY; Yokoyama T; Kuma H; Gu H; Li HP; Matsumoto Y; Yamaoka I; Fusumada K; Imagawa T; Wang ZY; Nakamura Y; Takeuchi Y
    Okajimas Folia Anat Jpn; 2006 May; 83(1):1-6. PubMed ID: 16862745
    [TBL] [Abstract][Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.